FindTrial
Sign In

Electrophysiological characterisation of yoga nidra and its role in Insomnia ( sleeplessness)patients

Electrophysiological characterisation of yoga nidra and its role in insomnia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/05/003682
Enrollment
90
Registered
2013-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Insomnia ( to study the role of yoga nidra in insomnia patients)

Interventions

Intervention1: Group II ( insomnia patients) subgroup B- Yoga Nidra: The intervention group would consist of insomnia patients and they would be given yoga nidra training for four weeks. Their convent

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group I Healthy subjects willing to participate in the study would be recruited. They should be following usual wake sleep schedule. Group II Patients should be following usual sleep wake schedule during the study period. They should be symptomatic for atleast six months. They should be having atleast one sleep symptom and one wake symptom for diagnosis of insomnia . Sleep symptom of difficulty initiating/ maintaining sleep/ early morning awakening or non restorative or non refreshing sleep, or combination of these sleep symptoms. Wake symptom comprising of sleep associated day time impairment e.g. sleepiness, fatigue, mood disturbances, cognitive difficulties, social impairment or occupational impairment.

Exclusion criteria

Exclusion criteria: History of any acute illness in the preceding one month which is likely to cause sleep disturbance would be considered exclusion criteria. Insomnia patients with symptoms for less than six months would be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Group I Electrophysiological monitoring using EEG, EMG, EOG, Pre Sleep Arousal Scale Salivary Cortisol Group II Overnight Polysomnography Insomnia severity index Pittsburgh Sleep Quality Index Pre Sleep Arousal Scale Salivary CortisolTimepoint: Baseline and after 4 weeks—

Secondary

MeasureTime frame
Group I- Pre sleep arousal scale, salivary cortisolTimepoint: 2 weeks;Group II- Insomnia severity index Pre Sleep Arousal Scale Salivary CortisolTimepoint: 2 weeks—

Countries

India

Contacts

Public ContactDr HN Mallick

All India Institute of Medical Sciences

manjari.tripathi1@gmail.com011-26594494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 27, 2026